一项随机对照试验的协议,用于在自闭症成年人 (i-Sleep Autism) 中治疗失眠的指导互联网认知行为疗法
Kirsten L Spaargaren1, Sander M Begeer1, Kirstin Greaves-Lord2
1Department of Clinical, Neuro-, and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Contemporary clinical trials
|October 2, 2024
概括
这项研究测试了针对自闭症成年人进行的失眠 (iCBT-I) 干预指导性基于互联网的认知行为疗法. 结果将显示这种电子健康方法是否有效地治疗这一群体的失眠.
科学领域:
- 神经发育障碍 神经发育障碍
- 睡眠医学 睡眠医学
- 数字健康数字健康
背景情况:
- 自闭症成年人患失眠率高 (60%),严重影响生活质量.
- 基于互联网的失眠认知行为疗法 (iCBT-I) 提供了一个可扩展的治疗选择.
- 由于自闭症成年人的独特处理和社会挑战,需要针对自闭症成年人量身定制的干预措施.
研究的目的:
- 评估引导性iCBT-I干预 (i-Sleep自闭症) 对患有失眠的自闭症成年人的有效性.
- 为了解决为这一群体量身定制的睡眠干预措施的短缺问题.
主要方法:
- 一个双臂,并行,优势随机对照试验,涉及160名患有失眠的自闭症成人.
- 参与者被随机分配到i-Sleep自闭症或仅信息等候名单对照组.
- 失眠严重程度是主要结局,次要结局包括心理健康和日常功能,在6周和6个月的随访中进行评估.
主要成果:
- 与对照组相比,i-Sleep自闭症的有效性目前正在评估中.
- 分析将使用线性混合效应回归模型.
- 将探索治疗有效性的潜在调节者和调解者.
结论:
- 这项试验将确定自闭症成人失眠是否受益于指导式电子健康干预.
- 结果可以为自闭症患者开发可访问和有效的睡眠治疗提供信息.
相关概念视频
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


